X
XtalPi
Artificial intelligence (AI) pharmaceutical firm
At a glance
- Founded
- 2014
- Headquarters
- Shenzhen, China
- Listing
- IPO 2024
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Research & analysis
Latest news
Press, funding announcements and product moves mentioning XtalPi.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later13 investors entered at this stage
- MPMorningside Venture Partners
SoftBank- CIChina Life Insurance
- PCPICC Capital
5Y Capital- SBSino Biopharmaceutical
- RCRRJ Capital
- MTMassachusetts Institute of Technology
- SCSIG China
Sequoia
SoftBank Vision Fund
Alphabet | Google
OrbiMed
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
341 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where XtalPi was the backer or acquirer, 2020–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
19 deals across XtalPi's capital deployment.
Where the deals concentrate by sector, stage, and decade.
XtalPi's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about XtalPi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See XtalPi on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.